TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #14729 · May 21

#csharp#c_sharp#linq#unity ZLinq is a high-performance, zero-allocation LINQ library for .NET and game engines like Unity and Godot. It improves on regular LINQ by avoiding memory allocations during method chaining, boosting speed and efficiency, especially in demanding apps like games. You use it by calling `AsValueEnumerable()` on collections, enabling faster queries with almost full compatibility with .NET 10 LINQ features. It supports advanced operations on arrays, spans, trees (like file systems and JSON), and SIMD for parallel processing. ZLinq also offers drop-in replacements to accelerate existing LINQ code without rewriting. This means you get faster, more memory-efficient data processing with minimal code changes[1][3][4]. https://github.com/Cysharp/ZLinq

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选
Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment